Source:http://linkedlifedata.com/resource/pubmed/id/19772380
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2010-6-30
|
pubmed:abstractText |
The contact time of a vehicle on the cornea is of utmost importance for ophthalmic drug delivery. The poor bioavailability and therefore poor therapeutic response exhibited by the conventional ophthalmic solutions due to pre-corneal elimination of a drug may be overcome by the use of the in situ gel forming systems, which upon instillation as drops into the eye, undergo a sol-gel transition in the cul-de-sac. The purpose of this work was to develop an ophthalmic delivery system of the forskolin, based on the concept of temperature activated in situ gelation. Poloxamer 407 (Pluronic F-127) is a block copolymer made of poly (oxy ethylene) and poly (oxy propylene). The sol-gel transition is induced by an increase in temperature; however, it depends on the concentration of the polymer and presence of other additives. The developed formulations were therapeutically efficacious (on albino New Zealand rabbit model); reducing intra ocular pressure (IOP) for 12 hours and showed sol-gel phase transition (gelling) temperature of 22 degrees C and sustained drug release 72% +/- 0.056% in vitro behavior over a period of 4 h.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Delayed-Action Preparations,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Carriers,
http://linkedlifedata.com/resource/pubmed/chemical/Excipients,
http://linkedlifedata.com/resource/pubmed/chemical/Forskolin,
http://linkedlifedata.com/resource/pubmed/chemical/Gels,
http://linkedlifedata.com/resource/pubmed/chemical/Poloxamer
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1097-9867
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
386-93
|
pubmed:meshHeading |
pubmed-meshheading:19772380-Administration, Topical,
pubmed-meshheading:19772380-Animals,
pubmed-meshheading:19772380-Biological Availability,
pubmed-meshheading:19772380-Cornea,
pubmed-meshheading:19772380-Delayed-Action Preparations,
pubmed-meshheading:19772380-Disease Models, Animal,
pubmed-meshheading:19772380-Drug Carriers,
pubmed-meshheading:19772380-Drug Delivery Systems,
pubmed-meshheading:19772380-Excipients,
pubmed-meshheading:19772380-Forskolin,
pubmed-meshheading:19772380-Gels,
pubmed-meshheading:19772380-Glaucoma,
pubmed-meshheading:19772380-Intraocular Pressure,
pubmed-meshheading:19772380-Male,
pubmed-meshheading:19772380-Poloxamer,
pubmed-meshheading:19772380-Rabbits,
pubmed-meshheading:19772380-Temperature,
pubmed-meshheading:19772380-Time Factors
|
pubmed:articleTitle |
Design and evaluation of thermoreversible in situ gelling system of forskolin for the treatment of glaucoma.
|
pubmed:affiliation |
Department of Pharmaceutics, J.S.S. College of Pharmacy, Ooty, India. saurabh109@yahoo.com
|
pubmed:publicationType |
Journal Article
|